Bioequivalence of Liquid and Reconstituted Lyophilized Subcutaneous Formulations of Caplacizumab.

Clinical trial NCT02189733 · COMPLETED

Trial details

NCT number: NCT02189733
Sponsor: Ablynx, a Sanofi company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2014-07-01
Primary completion: 2014-09-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.